Atlas Trials

Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis

Clinical trial NCT04543643 · UNKNOWN

Trial details

NCT number
NCT04543643
Sponsor
Tianjin Second People's Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Cirrhosis Due to Hepatitis BCirrhosis Due to Hepatitis CGastroesophageal Varices
Start date
2021-11-01
Primary completion
2023-10-31
Enrollment
288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.